EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Increased B-Type Natriuretic Peptide Concentration Is Associated with Reduced Coronary Vasoreactivity in Patients with Dilated Cardiomyopathy but Not in Healthy Young Subjects

Jan Sundell, Erik Engblom, Juhani Koistinen, Antti Ylitalo, Hanna Laine, Riikka Kalliokoski, K. E. Juhani Airaksinen, Jeroen J. Bax, Juhani Knuuti

ISRN Cardiology · 2011

DOI: 10.5402/2011/638764 ↗
AbstractBibliografische Angaben

Abstract

Background/Aims . Natriuretic peptides are associated with the cardiovascular disease risk under a range of different circumstances. However, less is known about whether this association is found also in young healthy subjects. Methods . 9 patients with dilated cardiomyopathy and 26 healthy young subjects were studied. The myocardial blood flow measurements were performed basally and during adenosine infusion using PET. Results . S-proBNP concentrations were significantly higher ( 2153 ± 1964 versus 28 ± 17 ng/L, P = .000002 ) and adenosine-stimulated flow lower ( 1.6 ± 0.8 versus 3.6 ± 1.1 mL ⋅ g −1 ⋅ min −1 , P = .00001 ) in patients with dilated cardiomyopathy when compared to healthy subjects. S-proBNP concentration was inversely associated with adenosine stimulated flow in patients with dilated cardiomyopathy ( r = − 0.75 , P = .019 ) but not in healthy subjects ( r = − 0.06 , P = .84 ). Conclusions . Natriuretic peptides are inversely associated with coronary vasoreactivity in patients with dilated cardiomyopathy but not in healthy young subjects. Since reduced coronary vasoreactivity seems to be one of the earliest abnormalities in the development of coronary artery disease, this might indicate that natriuretic peptides are not predictor of cardiovascular disease risk in healthy young subjects.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →